VR Logo

Ind-Swift Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1995

Chairman: N R Munjal

Managing Director: N R Munjal

Group: --

Listing: NSE: INDSWFTLAB, BSE: 532305

Headquarters: Chandigarh, Punjab

Website: www.indswiftlabs.com

Key Facts

Market cap: R 147.72 Cr

Revenue (TTM): R 777.01 Cr

Earnings (TTM): R -65.82 Cr

Cash: R 29.97 Cr

Total Debt: R 1,148.21 Cr

Promoters' ownership: 52.16%

Liquidity: Moderate

52 Week range: R 15.00 - 49.60

Face value: R10.00

Shares outstanding: 5,90,86,860

10 Years Aggregate:

  • CFO: 435.63 Cr
  • EBITDA: 1,178.60 Cr
  • Net Profit: -161.68 Cr

Stock Performance

Time Period Ind-Swift Laboratories S&P BSE Healthcare S&P BSE Small Cap
YTD6.8417.93-15.54
1 month16.823.294.22
3 months39.6613.75-15.99
1 Year-29.5817.97-22.54
3 Years-13.794.50-8.90
5 Years-5.59-0.111.33
10 Years-9.6111.122.98
As on 03-Jun-2020
Year Ind-Swift Laboratories S&P BSE Small Cap S&P BSE Healthcare
2019-51.85-6.85-3.55
2018-36.33-23.41-5.89
2017111.6059.640.49
2016-4.491.77-12.88
201523.676.7615.06
2014-36.3169.2447.43
2013-20.85-11.2322.55